Last reviewed · How we verify
Placebo Inhaltion Powder
Placebo Inhaltion Powder is a Small molecule drug developed by GlaxoSmithKline. It is currently in Phase 3 development.
A placebo inhalation powder that contains no active pharmaceutical ingredient and serves as a control comparator in clinical trials.
At a glance
| Generic name | Placebo Inhaltion Powder |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebo formulations are inert substances designed to mimic the appearance, taste, and administration route of an active drug without providing any pharmacological effect. In this case, the placebo is formulated as an inhalation powder to match the delivery method of the investigational active drug being tested, allowing for blinded comparison in phase 3 clinical trials.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo Inhaltion Powder CI brief — competitive landscape report
- Placebo Inhaltion Powder updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI
Frequently asked questions about Placebo Inhaltion Powder
What is Placebo Inhaltion Powder?
How does Placebo Inhaltion Powder work?
Who makes Placebo Inhaltion Powder?
What development phase is Placebo Inhaltion Powder in?
Related
- Manufacturer: GlaxoSmithKline — full pipeline
- Compare: Placebo Inhaltion Powder vs similar drugs
- Pricing: Placebo Inhaltion Powder cost, discount & access